Search In this Thesis
   Search In this Thesis  
العنوان
Screening for Hepatocellular Carcinoma in patients with :
المؤلف
EltabbakhEl, Mohamed Ahmed Mohamed Abd El-wahab.
هيئة الاعداد
باحث / محمد أحمد محمد عبد الوهاب الطباخ
مشرف / إمام عبد اللطيف واكد
مشرف / حسن أحمد الشناوي
مناقش / حسن السيد زغله
الموضوع
Liver - Cancer. Liver Neoplasms - therapy.
تاريخ النشر
2014 .
عدد الصفحات
121 p. :
اللغة
الإنجليزية
الدرجة
الدكتوراه
التخصص
الكبد
تاريخ الإجازة
22/7/2014
مكان الإجازة
جامعة المنوفية - معهد الكبد - قسم الباطنة
الفهرس
Only 14 pages are availabe for public view

from 121

from 121

Abstract

Hepatocellular carcinoma is a major complication of chronic liver diseases and had the poorest diagnosis.
• The incidence of hepatocellular carcinoma is 5.3% which is higher than in western countries and lower than eastern countries
• Surveillance for HCC results in detection of smaller lesions before development of portal vein thrombosis or extrahepatic spread while the patient had good liver functions which give the patients better chance for curative treatment.
• Addition of alpha fetoprotein to ultrasound examination results in significant increase in the efficacy of screening program.
• The cost/ QALY for HCC detected by screening by ultrasound alone 7,907 EGP while adding alpha fetoprotein to ultrasound examination costs 8,430 EGP.
• ICER by screening by ultrasound alone is 5,987 EGP when screening done by ultrasound alone, while by ultrasound and AFP is 6,430 EGP.
• Either screening by ultrasound alone or by ultrasound with alpha fetoprotein is cost effectiveness in Egypt.